Prostamax 20mg
Prostate Tissue Peptide Bioregulator for Glandular Research
Prostamax is a Khavinson tetrapeptide bioregulator targeting prostate gland tissue, normalizing gene expression in prostate cells to support prostate health and function.
Prostate Tissue Peptide Bioregulator for Glandular Research
Prostate-specific peptide bioregulator supporting normal prostate epithelial gene expression through epigenetic modulation, relevant for prostate health and aging research.
As one of the most studied compounds in the recovery & healing research space, Prostamax has attracted sustained scientific interest across Prostate health research, Glandular aging studies. Peer-reviewed evidence indicates that prostate-specific Khavinson bioregulator, which has positioned Prostamax as a reference standard for researchers exploring prostate health research outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
Prostamax Documented Benefits: 1 Documented Mechanisms
Prostate Tissue Support
Normalizes gene expression in prostate glandular cells for tissue health.
How Prostamax Works: Molecular Mechanism & Pathway
Short peptide with prostate tissue specificity for epigenetic gene expression normalization.
The 1 primary research pathways identified for Prostamax — Prostate Tissue Support — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that glandular gene expression support, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, Prostamax's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
Prostamax is routinely studied alongside TA-1 and Thymulin in recovery & healing-focused compound panels. Researchers investigating prostate health research have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that 20mg research format has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All Prostamax research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- Prostate-specific Khavinson bioregulator
- Glandular gene expression support
- 20mg research format
Ideal For
- Prostate health research
- Glandular aging studies
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on Prostamax. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
Prostate-specific Khavinson bioregulator
Glandular gene expression support
20mg research format
Third-Party Verified Every Batch
Each vial of Prostamax is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
